The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis

References

• Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol. 2011;7:631–8.
   PubMed Web of Science ®Google Scholar
• Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurology. 2009;8:94–109.
   PubMed Web of Science ®Google Scholar
• Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc’h P, et al. 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PloS One. 2010; 5:e13223.
   PubMed Web of Science ®Google Scholar
• Kumar A, Bala L, Kalita J, Misra UK, Singh RL, Khetrapal CL, et al. Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. Clinica chimica acta; international journal of clinical chemistry. 2010;411:563–7.
   PubMed Web of Science ®Google Scholar
• Lawton KA, Brown MV, Alexander D, Li Z, Wulff JE, Lawson R, et al. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15: 362–70.
   PubMed Web of Science ®Google Scholar
• Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, et al. Metabolomic analysis and signatures in motor neuron disease. Metabolomics : Official journal of the Metabolomic Society. 2005;1:101–8.
   PubMed Web of Science ®Google Scholar
• Blasco H, Corcia P, Pradat PF, Bocca C, Gordon PH, Veyrat-Durebex C, et al. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. Journal of Proteome Research. 2013;12:3746–54.
   PubMed Web of Science ®Google Scholar
• Lawton KA, Cudkowicz ME, Brown MV, Alexander D, Caffrey R, Wulff JE, et al. Biochemical alterations associated with ALS. Amyotrophic Lateral Sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2012;13:110–8.
   PubMed Web of Science ®Google Scholar
• Wuolikainen A, Andersen PM, Moritz T, Marklund SL, Antti H. ALS patients with mutations in the SOD1 gene have a unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations. Molecular Genetics and Metabolism. 2012;105:472–8.
   PubMed Web of Science ®Google Scholar
• Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM. Disease related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PloS One. 2011;6:e17947.
   PubMed Web of Science ®Google Scholar
• Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 (Suppl 1):19–32.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Waterman CL, Currie RA, Cottrell LA, Dow J, Wright J, Waterfield CJ, et al. An integrated functional genomic study of acute phenobarbital exposure in the rat. BMC Genomics. 2010;11:9.
   PubMed Web of Science ®Google Scholar
• Skov T, van den Berg F, Tomasi G, Bro R. Automated alignment of chromatographic data. Journal of Chemometrics. 2006;20:484–97.
   Web of Science ®Google Scholar
• Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. HMDB 3.0: The Human Metabolome Database in2013. Nucleic acids research. 2013;41(Database issue):D801–7.
   Google Scholar
• Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, et al. The human cerebrospinal fluid metabolome. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2008;871:164–73.
   PubMed Web of Science ®Google Scholar
• Blasco H, Nadal-Desbarats L, Pradat PF, Gordon PH, Antar C, Veyrat-Durebex C, et al. Untargeted 1H-NMR metabolomics in CSF: towards a diagnostic biomarker for motor neuron disease. Neurology. 2014;82:1167–74.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992;326:1464–8.
   PubMed Web of Science ®Google Scholar
• Bacman SR, Bradley WG, Moraes CT. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target? Mol Neurobiol. 2006;33:113–31.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328–34.
   PubMed Web of Science ®Google Scholar
• Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2009;10:113–7.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurology. 2011;10:75–82.
   PubMed Web of Science ®Google Scholar
• Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegenerative Diseases. 2005;2:202–7.
   PubMed Web of Science ®Google Scholar
• Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. The American Journal of Clinical Nutrition. 1996;63:130–7.
   PubMed Web of Science ®Google Scholar
• de Jong SW, Huisman MH, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, et al. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population based study. American Journal of Epidemiology. 2012;176:233–9.
   PubMed Web of Science ®Google Scholar
• McManus IR, Contag AO, Olson RE. Characterization of Endogenous Ethanol in the Mammal. Science (New York, NY). 1960;131:102–3.
   Web of Science ®Google Scholar
• Walker GW, Curry AS. ‘Endogenous’ alcohol in body fluids. Nature. 1966;210:1368.
   PubMed Web of Science ®Google Scholar
• Jones AW, Mardh G, Anggard E. Determination of endogenous ethanol in blood and breath by gas chromatography-mass spectrometry. Pharmacology, Biochemistry, and Behavior. 1983;18 (Suppl 1):267–72.
   PubMed Web of Science ®Google Scholar
• Antoshechkin AG. On intracellular formation of ethanol and its possible role in energy metabolism. Alcohol and Alcoholism (Oxford, Oxfordshire). 2001;36:608.
   PubMed Web of Science ®Google Scholar
• Meshitsuka S, Morio Y, Nagashima H, Teshima R. 1H-NMR studies of cerebrospinal fluid: endogenous ethanol in patients with cervical myelopathy. Clinica chimica acta; international journal of clinical chemistry. 2001;312:25–30.
   PubMed Web of Science ®Google Scholar
• Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E, et al. Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med. 2012;4:38.
   PubMed Web of Science ®Google Scholar
• Benatar M, Wuu J. Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology. 2012; 79:1732–9.
   PubMed Web of Science ®Google Scholar